Åsa Malmberg

808 total citations
20 papers, 583 citations indexed

About

Åsa Malmberg is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Åsa Malmberg has authored 20 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 3 papers in Psychiatry and Mental health. Recurrent topics in Åsa Malmberg's work include Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). Åsa Malmberg is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). Åsa Malmberg collaborates with scholars based in Sweden, United Kingdom and Austria. Åsa Malmberg's co-authors include Nina Mohell, Anders Eriksson, D M Jackson, Uli Hacksell, Gunnar Nordvall, Eva Jerning, Åsa Mikaels, David M. Jackson, Anna‐Karin Johansson and Erik Wallström and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Åsa Malmberg

19 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Åsa Malmberg Sweden 13 401 368 89 41 38 20 583
Berthold Behl Germany 15 273 0.7× 250 0.7× 57 0.6× 25 0.6× 15 0.4× 25 494
Jean Ménager France 15 366 0.9× 426 1.2× 25 0.3× 20 0.5× 30 0.8× 20 616
Ellinor Grinde United States 13 578 1.4× 654 1.8× 53 0.6× 20 0.5× 29 0.8× 15 883
Paula te Riele Belgium 10 236 0.6× 236 0.6× 42 0.5× 14 0.3× 32 0.8× 16 433
Nikolas Stroth Sweden 16 403 1.0× 270 0.7× 25 0.3× 29 0.7× 28 0.7× 25 665
Jens Nagel Germany 18 490 1.2× 328 0.9× 51 0.6× 24 0.6× 104 2.7× 33 805
P M Laduron Belgium 10 548 1.4× 490 1.3× 57 0.6× 45 1.1× 25 0.7× 15 793
Cindy Wintmolders Belgium 13 362 0.9× 296 0.8× 39 0.4× 21 0.5× 23 0.6× 16 569
Julie V. Selkirk United States 12 291 0.7× 306 0.8× 26 0.3× 19 0.5× 20 0.5× 23 497
Sean M. Peterson United States 14 627 1.6× 820 2.2× 60 0.7× 36 0.9× 64 1.7× 23 1.1k

Countries citing papers authored by Åsa Malmberg

Since Specialization
Citations

This map shows the geographic impact of Åsa Malmberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Malmberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Malmberg more than expected).

Fields of papers citing papers by Åsa Malmberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsa Malmberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Malmberg. The network helps show where Åsa Malmberg may publish in the future.

Co-authorship network of co-authors of Åsa Malmberg

This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Malmberg. A scholar is included among the top collaborators of Åsa Malmberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Malmberg. Åsa Malmberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babich, Olga, Olof Larsson, Per-Eric Lund, et al.. (2012). Identification of Novel NaV1.7 Antagonists Using High Throughput Screening Platforms. Combinatorial Chemistry & High Throughput Screening. 15(9). 713–720. 4 indexed citations
2.
Malmberg, Åsa. (2007). Evaluating the gender wage gap in Sweden. KTH Publication Database DiVA (KTH Royal Institute of Technology).
3.
Eriksson, Anders, et al.. (2004). In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine1B autoreceptor antagonist. European Journal of Pharmacology. 499(1-2). 67–75. 18 indexed citations
4.
Eltayeb, Sana, Dan Sunnemark, Anna‐Lena Berg, et al.. (2003). Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease. Journal of Neuroimmunology. 142(1-2). 75–85. 29 indexed citations
5.
6.
Malmberg, Åsa, et al.. (2001). AR-A000002, a high affinity 5-HT1B receptor ligand: In vitro pharmacological profile. European Neuropsychopharmacology. 11. S214–S215. 3 indexed citations
7.
8.
Linnanen, Tero, et al.. (1999). Derivatives of (R)-2-amino-5-methoxytetralin: Antagonists and inverse agonists at the dopamine D2 receptor. Bioorganic & Medicinal Chemistry Letters. 9(15). 2167–2172. 4 indexed citations
9.
Malmberg, Åsa, et al.. (1998). Interactions of ligands with active and inactive conformations of the dopamine D2 receptor. European Journal of Pharmacology. 346(2-3). 299–307. 19 indexed citations
10.
Malmberg, Åsa, Åsa Mikaels, & Nina Mohell. (1998). Agonist and Inverse Agonist Activity at the Dopamine D3 Receptor Measured by Guanosine 5′-[γ-Thio]Triphosphate-[35S] Binding. Journal of Pharmacology and Experimental Therapeutics. 285(1). 119–126. 27 indexed citations
11.
Yu, Hong, Ye Liu, Åsa Malmberg, et al.. (1996). Differential serotoninergic and dopaminergic activities of the ( R )- and the ( S )-enantiomers of 2-(di- n -propylamino) tetralin. European Journal of Pharmacology. 303(3). 151–162. 19 indexed citations
12.
Malmberg, Åsa, Eva Jerning, & Nina Mohell. (1996). Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. European Journal of Pharmacology. 303(1-2). 123–128. 26 indexed citations
13.
14.
Malmberg, Åsa, et al.. (1996). Novel (R)-2-Amino-5-fluorotetralins:  Dopaminergic Antagonists and Inverse Agonists. Journal of Medicinal Chemistry. 39(22). 4421–4429. 14 indexed citations
15.
Jackson, David M., Nina Mohell, Å. Bengtsson, & Åsa Malmberg. (1995). Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?. European Journal of Pharmacology. 282(1-3). 137–144. 5 indexed citations
16.
Malmberg, Åsa & Nina Mohell. (1995). Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 790–797. 57 indexed citations
17.
Jerning, Eva, Åsa Malmberg, & Nina Mohell. (1995). In Vitro Receptor Binding Characteristics of the New Dopamine D2Antagonist [125I]NCO-298: Methodological Considerations of High Affinity Binding. Journal of Receptors and Signal Transduction. 15(1-4). 503–515. 5 indexed citations
18.
Malmberg, Åsa, Gunnar Nordvall, Anna‐Karin Johansson, Nina Mohell, & Uli Hacksell. (1994). Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.. Molecular Pharmacology. 46(2). 299–312. 41 indexed citations
19.
Mohell, Nina, et al.. (1993). Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. European Journal of Pharmacology. 238(1). 121–125. 43 indexed citations
20.
Malmberg, Åsa, D M Jackson, Anders Eriksson, & Nina Mohell. (1993). Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.. Molecular Pharmacology. 43(5). 749–754. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Berthold Behl Breakdown of academic impact, for papers by Jean Ménager Breakdown of academic impact, for papers by Ellinor Grinde Breakdown of academic impact, for papers by Paula te Riele Breakdown of academic impact, for papers by Nikolas Stroth Breakdown of academic impact, for papers by Jens Nagel Breakdown of academic impact, for papers by P M Laduron Breakdown of academic impact, for papers by Cindy Wintmolders Breakdown of academic impact, for papers by Julie V. Selkirk Breakdown of academic impact, for papers by Sean M. Peterson
Rankless by CCL
2026